The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: Development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia

被引:39
|
作者
Skinner M.W. [1 ]
Chai-Adisaksopha C. [2 ,10 ]
Curtis R. [3 ]
Frick N. [4 ]
Nichol M. [5 ]
Noone D. [6 ]
O'Mahony B. [6 ,7 ]
Page D. [8 ]
Stonebraker J.S. [9 ]
Iorio A. [2 ,10 ]
机构
[1] Institute for Policy Advancement Ltd, 1155 23rd Street NW #3A, Washington, 20037, DC
[2] McMaster University, Department of Medicine, Hamilton
[3] Factor VIII Computing, Berkeley
[4] National Hemophilia Foundation, New York
[5] University of Southern California, Sol Price School of Public Policy, Los Angeles
[6] Irish Haemophilia Society, Dublin
[7] Trinity College Dublin, Dublin
[8] Canadian Hemophilia Society, Montreal
[9] North Carolina State University, Poole College of Management, Raleigh
[10] McMaster University, Department of Health Research Methods, Evidence, and Impact, Hamilton
关键词
Haemophilia; Patient-centered research; Patient-reported outcomes; Quality of life;
D O I
10.1186/s40814-018-0253-0
中图分类号
学科分类号
摘要
Background: The interest of health care agencies, private payers and policy makers for patient-reported outcomes (PRO) is continuously increasing. There is a substantial need to improve capacity to collect and interpret relevant PRO data to support implementation of patient-centered research and optimal care in haemophilia. The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project aims to develop a patient-led research network, to develop a standardized questionnaire to gather patient-reported outcomes and to perform a feasibility study of implementing the PROBE questionnaire. Methods: A pilot questionnaire was developed using focus group methodology. Content and face validity were assessed by a pool of persons living with haemophilia (PWH) and content experts through interactive workshops. The PROBE questionnaire was translated with the forward-backward approach. PROBE recruited national haemophilia patient non-governmental organizations (NGOs) to administer the questionnaire to people with and without haemophilia. PROBE measured the time to complete the questionnaire and gathered feedback on its content and clarity; staff time and cost required to implement the questionnaire were also collected. Results: The PROBE questionnaire is comprised of four major sections (demographic data, general health problems, haemophilia-related health problems and health-related quality of life using EQ-5D-5L and EQ-VAS). Seventeen NGOs participated in the pilot study of the PROBE Project, recruiting 656 participants. Of these, 71% completed the questionnaire within 15 min, and all participants completed within 30 min. The median total staff and volunteer time required for the NGOs to carry out the study within their country was 9 h (range 2 to 40 h). NGO costs ranged from $22.00 to $543.00 USD per country, with printing and postage being the most commonly reported expenditures. Conclusions: The PROBE questionnaire assesses patient-important reported outcomes in PWH and control participants, with a demonstrated short completion time. PROBE proved the feasibility to engage diverse patient communities in the structured generation of real-world outcome research at all stages. © 2018 The Author(s).
引用
收藏
相关论文
共 50 条
  • [11] Development and validation of the patient reported outcomes questionnaire of children with asthma in China: A Caregiver's proxy-reported measure
    Xu, Tong
    Zhang, Haiyue
    Zhang, Yuhai
    Yang, Peng
    Yang, Zhe
    Jiang, Xun
    Shang, Lei
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [12] Implementation of a methodology to assess patient reported outcomes in lung cancer patients: The PeOpLe (Patient-reported Outcomes in Lung cancer) study protocol
    Villanueva-Bueno, Cristina
    Collado-Borrell, Roberto
    Luis Revuelta-Herrero, Jose
    Beatriz Fernandez-Roman, Ana
    Casado-Abad, Gema
    Escudero-Vilaplana, Vicente
    FARMACIA HOSPITALARIA, 2022, 46 (04) : 265 - 269
  • [13] Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology
    Urretavizcaya, Mikel
    Alvarez, Karen
    Olariaga, Olatz
    Tames, Maria Jose
    Asensio, Ainhoa
    Cajaraville, Gerardo
    Riestra, Ana Cristina
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
  • [14] Exploring regional variations in the cross-cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study
    Chai-Adisaksopha, Chatree
    Skinner, Mark W.
    Curtis, Randall
    Frick, Neil
    Nichol, Michael B.
    Noone, Declan
    O'Mahony, Brian
    Page, David
    Stonebraker, Jeffrey
    Thabane, Lehana
    Crowther, Mark A.
    Iorio, Alfonso
    HAEMOPHILIA, 2019, 25 (03) : 365 - 372
  • [15] Patient Reported Outcomes in Microbial Keratitis
    Tuohy, Megan M.
    Niziol, Leslie M.
    Mian, Shazhad, I
    Ballouz, Dena
    Bosch, David
    Woodward, Maria A.
    CORNEA, 2021, 40 (01) : 19 - 25
  • [16] Patient Reported Outcomes in Orthopaedics
    Gagnier, Joel J.
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2017, 35 (10) : 2098 - 2108
  • [17] Integration of Patient Reported Outcomes in Drug Development in Genitourinary Cancers
    Wong, Risa L.
    Morgans, Alicia K.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (03)
  • [18] Evaluating patient reported outcomes and experiences in a novel proton beam clinic - challenges, activities, and outcomes of the ProtonCare project
    Sjoevall, K.
    Langegard, U.
    Fransson, P.
    Nevo-Ohlsson, E.
    Kristensen, I
    Ahlberg, K.
    Johansson, B.
    BMC CANCER, 2023, 23 (01)
  • [19] Identification of patient-reported outcomes measures (PROMs) and patient-reported experiences measures (PREMs) in Gaucher disease in Spain
    Giraldo, Pilar
    Camprodon, Maria
    Alcolea, Paloma Cerro
    Gras-Colomer, Elena
    Ibarretxe, Daiana
    Lakhwani, Sunil
    Mora, Elvira
    Calderon, Maria Purificacion Velasco
    Morales-Conejo, Montserrat
    MEDICINA CLINICA, 2024, 163 (09): : 449 - 457
  • [20] Evaluating patient reported outcomes and experiences in a novel proton beam clinic – challenges, activities, and outcomes of the ProtonCare project
    K Sjövall
    U Langegård
    P Fransson
    E Nevo-Ohlsson
    I Kristensen
    K Ahlberg
    B Johansson
    BMC Cancer, 23